• Health & Medicine

Cancer Won't Wait: "I prayed she would see her daughter start school"

We spoke to 4 people about why, when it comes to cancer, every second counts and why the Government must act now to ensure the NHS can catch more cancers early. We spoke to 4 people about why, when it comes to cancer, every second counts and why the Government must act now to ensure the NHS can catch more cancers early.

11 October 2021

• For Researchers

Prize winning early detection research

Professor Rebecca Fitzgerald on the power of collaboration, taking risks and the rise of early detection as a hot topic for researchers... Professor Rebecca Fitzgerald on the power of collaboration, taking risks and the rise of early detection as a hot topic for researchers...

7 October 2021

• For Researchers
• Science & Technology

Delivering the future of paediatric brain tumour therapy

Dr Lisa Ruff tells us why drug delivery is so important for the treatment of paediatric brain tumours – and why hydrogels could be key to a breakthrough… Dr Lisa Ruff tells us why drug delivery is so important for the treatment of paediatric brain tumours – and why hydrogels could be key to a breakthrough…

7 October 2021

• Health & Medicine

Investigating suspected prostate cancer: Improving GP-patient communication

A study published earlier this year uncovered some important differences in people's experience of visiting the GP. A study published earlier this year uncovered some important differences in people's experience of visiting the GP.

6 October 2021

• Health & Medicine

New drug available for rare thyroid cancer on NHS in England

The National Institute for Health and Care Excellence (NICE) has recommended the use of the drug selpercatinib (Retevmo) for some people in England with a type of advanced thyroid cancer. The National Institute for Health and Care Excellence (NICE) has recommended the use of the drug selpercatinib (Retevmo) for some people in England with a type of advanced thyroid cancer.

1 October 2021

• Health & Medicine

Cancer in children and young people: how far we’ve come

Since the 1970s, 30,000 deaths have been avoided thanks in part to the progress we’ve made in diagnosing and treating children's and young people's cancers. Since the 1970s, 30,000 deaths have been avoided thanks in part to the progress we’ve made in diagnosing and treating children's and young people's cancers.

29 September 2021

• Science & Technology

A winding journey into the world of children’s and young people’s cancer research

We hear from two Cancer Research UK scientists, Ashley Nicholls and Jessica Taylor, about their interesting career changes. We hear from two Cancer Research UK scientists, Ashley Nicholls and Jessica Taylor, about their interesting career changes.

24 September 2021

• For Researchers
• Health & Medicine

Making the most of your ‘eureka’ moment: getting from the science to the clinic

How can we make the vital journey from research to clinical impact more efficient? It all comes down to empowering researchers to develop an entrepreneurial mindset How can we make the vital journey from research to clinical impact more efficient? It all comes down to empowering researchers to develop an entrepreneurial mindset

22 September 2021

• Health & Medicine

Cancer target missed for 55,000 patients over 6 years

In the last 6 years, almost 55,000 cancer patients should have been diagnosed or started their treatment sooner, according to new calculations. In the last 6 years, almost 55,000 cancer patients should have been diagnosed or started their treatment sooner, according to new calculations.

22 September 2021

• For Researchers

A celebration of peer review

As part of Peer Review Week, we are very proud to celebrate the essential role our research community play in this process. Here we chat to Professor Marcus Munafò – a member of one of our funding committees As part of Peer Review Week, we are very proud to celebrate the essential role our research community play in this process. Here we chat to Professor Marcus Munafò – a member of one of our funding committees

21 September 2021

• Health & Medicine
• Science & Technology

Precision drug slows progression of advanced breast cancer

Patients taking the drug trastuzumab deruxecan were 72% less likely to see their cancer grow significantly or to die than those on an existing breast cancer treatment. Patients taking the drug trastuzumab deruxecan were 72% less likely to see their cancer grow significantly or to die than those on an existing breast cancer treatment.

21 September 2021